 CRANBURY, N.J., June 08, 2022 GLOBE NEWSWIRE -- PMV Pharmaceuticals, Inc. Nasdaq: PMVP; PMV Pharma, a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced that David H. Mack, Ph.D., President Chief Executive Officer of PMV Pharmaceuticals, will participate in a fireside chat at the Goldman Sachs Global Healthcare Conference taking place in Ranchos Palos Verdes, California June 14-16, 2022. 